• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

结直肠癌细胞在肝脏形成转移灶时的适应性:小鼠模型中相关基因和信号通路的表达

The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model.

作者信息

Bocuk Derya, Wolff Alexander, Krause Petra, Salinas Gabriela, Bleckmann Annalen, Hackl Christina, Beissbarth Tim, Koenig Sarah

机构信息

Department of General, Visceral and Paediatric Surgery, University Medical Centre, Georg - August - University Goettingen, Göttingen, Germany.

Statistical Bioinformatics, Department of Medical Statistics, University Medical Centre, Georg - August - University Goettingen, Göttingen, Germany.

出版信息

BMC Cancer. 2017 May 19;17(1):342. doi: 10.1186/s12885-017-3342-1.

DOI:10.1186/s12885-017-3342-1
PMID:28525976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5437520/
Abstract

BACKGROUND

Colorectal cancer (CRC) is the second leading cause of cancer-related death in men and women. Systemic disease with metastatic spread to distant sites such as the liver reduces the survival rate considerably. The aim of this study was to investigate the changes in gene expression that occur on invasion and expansion of CRC cells when forming metastases in the liver.

METHODS

The livers of syngeneic C57BL/6NCrl mice were inoculated with 1 million CRC cells (CMT-93) via the portal vein, leading to the stable formation of metastases within 4 weeks. RNA sequencing performed on the Illumina platform was employed to evaluate the expression profiles of more than 14,000 genes, utilizing the RNA of the cell line cells and liver metastases as well as from corresponding tumour-free liver.

RESULTS

A total of 3329 differentially expressed genes (DEGs) were identified when cultured CMT-93 cells propagated as metastases in the liver. Hierarchical clustering on heat maps demonstrated the clear changes in gene expression of CMT-93 cells on propagation in the liver. Gene ontology analysis determined inflammation, angiogenesis, and signal transduction as the top three relevant biological processes involved. Using a selection list, matrix metallopeptidases 2, 7, and 9, wnt inhibitory factor, and chemokine receptor 4 were the top five significantly dysregulated genes.

CONCLUSION

Bioinformatics assists in elucidating the factors and processes involved in CRC liver metastasis. Our results support the notion of an invasion-metastasis cascade involving CRC cells forming metastases on successful invasion and expansion within the liver. Furthermore, we identified a gene expression signature correlating strongly with invasiveness and migration. Our findings may guide future research on novel therapeutic targets in the treatment of CRC liver metastasis.

摘要

背景

结直肠癌(CRC)是男性和女性癌症相关死亡的第二大主要原因。发生转移扩散至肝脏等远处部位的全身性疾病会显著降低生存率。本研究的目的是调查CRC细胞在肝脏形成转移灶时侵袭和扩散过程中发生的基因表达变化。

方法

通过门静脉向同基因C57BL/6NCrl小鼠的肝脏接种100万个CRC细胞(CMT-93),4周内可稳定形成转移灶。利用Illumina平台进行RNA测序,以细胞系细胞、肝脏转移灶以及相应的无瘤肝脏的RNA评估14000多个基因的表达谱。

结果

当培养的CMT-93细胞在肝脏中转移增殖时,共鉴定出3329个差异表达基因(DEG)。热图上的层次聚类显示了CMT-93细胞在肝脏中增殖时基因表达的明显变化。基因本体分析确定炎症、血管生成和信号转导为涉及的前三个相关生物学过程。使用一个选择列表,基质金属肽酶2、7和9、Wnt抑制因子和趋化因子受体4是前五个显著失调的基因。

结论

生物信息学有助于阐明CRC肝转移所涉及的因素和过程。我们的结果支持这样一种观点,即侵袭-转移级联反应涉及CRC细胞在肝脏内成功侵袭和扩展后形成转移灶。此外,我们鉴定出了一种与侵袭性和迁移密切相关的基因表达特征。我们 的发现可能会为未来CRC肝转移治疗新靶点的研究提供指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/e558955b450b/12885_2017_3342_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/7932692b3a6a/12885_2017_3342_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/901b6c00b393/12885_2017_3342_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/a0f34c500506/12885_2017_3342_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/b22167c2e149/12885_2017_3342_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/e558955b450b/12885_2017_3342_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/7932692b3a6a/12885_2017_3342_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/901b6c00b393/12885_2017_3342_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/a0f34c500506/12885_2017_3342_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/b22167c2e149/12885_2017_3342_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f2d4/5437520/e558955b450b/12885_2017_3342_Fig5_HTML.jpg

相似文献

1
The adaptation of colorectal cancer cells when forming metastases in the liver: expression of associated genes and pathways in a mouse model.结直肠癌细胞在肝脏形成转移灶时的适应性:小鼠模型中相关基因和信号通路的表达
BMC Cancer. 2017 May 19;17(1):342. doi: 10.1186/s12885-017-3342-1.
2
SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival.SPON2,MACC1 的一个新鉴定靶基因,驱动结直肠癌在小鼠中的转移,并且是结直肠癌患者生存的预后标志物。
Oncogene. 2016 Nov 17;35(46):5942-5952. doi: 10.1038/onc.2015.451. Epub 2015 Dec 21.
3
Inhibition of miR-15b decreases cell migration and metastasis in colorectal cancer.抑制miR-15b可降低结直肠癌的细胞迁移和转移能力。
Tumour Biol. 2016 Jul;37(7):8765-73. doi: 10.1007/s13277-015-4396-9. Epub 2016 Jan 7.
4
Pea3 expression promotes the invasive and metastatic potential of colorectal carcinoma.Pea3表达促进结直肠癌的侵袭和转移潜能。
World J Gastroenterol. 2014 Dec 14;20(46):17376-87. doi: 10.3748/wjg.v20.i46.17376.
5
Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.通过调节成纤维细胞生长因子受体 1 的表达鉴定 microRNA-214 作为结直肠癌肝转移的负调节剂。
Hepatology. 2014 Aug;60(2):598-609. doi: 10.1002/hep.27118. Epub 2014 May 28.
6
Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.结直肠癌细胞中 SMAD4 的缺失促进 CCL15 的表达,募集 CCR1+髓样细胞并促进肝转移。
Gastroenterology. 2013 Nov;145(5):1064-1075.e11. doi: 10.1053/j.gastro.2013.07.033. Epub 2013 Jul 25.
7
New Wnt/β-catenin target genes promote experimental metastasis and migration of colorectal cancer cells through different signals.新的 Wnt/β-catenin 靶基因通过不同信号促进结直肠癌细胞的实验转移和迁移。
Gut. 2016 Oct;65(10):1690-701. doi: 10.1136/gutjnl-2014-307900. Epub 2015 Jul 8.
8
Identification of microRNA 885-5p as a novel regulator of tumor metastasis by targeting CPEB2 in colorectal cancer.通过靶向CPEB2鉴定微小RNA 885-5p作为结直肠癌肿瘤转移的新型调节因子
Oncotarget. 2017 Apr 18;8(16):26858-26870. doi: 10.18632/oncotarget.15844.
9
FOXC2 promotes colorectal cancer metastasis by directly targeting MET.FOXC2 通过直接靶向 MET 促进结直肠癌转移。
Oncogene. 2015 Aug 13;34(33):4379-90. doi: 10.1038/onc.2014.368. Epub 2014 Nov 10.
10
Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.血管内皮生长因子 C 破坏内皮淋巴管屏障促进结直肠癌侵袭。
Gastroenterology. 2015 Jun;148(7):1438-51.e8. doi: 10.1053/j.gastro.2015.03.005. Epub 2015 Mar 6.

引用本文的文献

1
The Future of ctDNA-Defined Minimal Residual Disease: Personalizing Adjuvant Therapy in Colorectal Cancer.ctDNA 定义的微小残留病灶的未来:结直肠癌辅助治疗的个体化。
Clin Colorectal Cancer. 2022 Jun;21(2):89-95. doi: 10.1016/j.clcc.2022.03.004. Epub 2022 Mar 26.
2
High-throughput microscopy reveals the impact of multifactorial environmental perturbations on colorectal cancer cell growth.高通量显微镜揭示了多因素环境干扰对结直肠癌细胞生长的影响。
Gigascience. 2021 Apr 19;10(4). doi: 10.1093/gigascience/giab026.
3
Aberrant methylation and microRNA-target regulation are associated with downregulated NEURL1B: a diagnostic and prognostic target in colon cancer.

本文引用的文献

1
Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G).贝伐珠单抗联合 FOLFIRI 和贝伐珠单抗联合 mFOLFOX6 作为转移性结直肠癌一线治疗的随机 III 期研究(WJOG4407G)。
Ann Oncol. 2016 Aug;27(8):1539-46. doi: 10.1093/annonc/mdw206. Epub 2016 May 13.
2
Immune and Stromal Classification of Colorectal Cancer Is Associated with Molecular Subtypes and Relevant for Precision Immunotherapy.结直肠癌的免疫和基质分类与分子亚型相关,并与精准免疫治疗相关。
Clin Cancer Res. 2016 Aug 15;22(16):4057-66. doi: 10.1158/1078-0432.CCR-15-2879. Epub 2016 Mar 18.
3
异常甲基化和微小RNA靶向调控与NEURL1B下调相关:NEURL1B是结肠癌的一个诊断和预后靶点。
Cancer Cell Int. 2020 Jul 27;20:342. doi: 10.1186/s12935-020-01379-5. eCollection 2020.
IFNα gene/cell therapy curbs colorectal cancer colonization of the liver by acting on the hepatic microenvironment.
IFNα 基因/细胞疗法通过作用于肝脏微环境来抑制结直肠癌在肝脏的定植。
EMBO Mol Med. 2016 Feb 1;8(2):155-70. doi: 10.15252/emmm.201505395.
4
Genome-wide mutation profiles of colorectal tumors and associated liver metastases at the exome and transcriptome levels.结直肠癌肿瘤及其相关肝转移灶在全外显子组和转录组水平的全基因组突变图谱。
Oncotarget. 2015 Sep 8;6(26):22179-90. doi: 10.18632/oncotarget.4246.
5
Bevacizumab with FOLFIRI or XELIRI in the First-line Therapy of Metastatic Colorectal Carcinoma: Results from Czech Observational Registry.贝伐单抗联合FOLFIRI或XELIRI用于转移性结直肠癌一线治疗:捷克观察性登记研究结果
Anticancer Res. 2015 Jun;35(6):3455-61.
6
Integrating systemic and surgical approaches to treating metastatic colorectal cancer.整合全身治疗与手术方法治疗转移性结直肠癌。
Surg Oncol Clin N Am. 2015 Jan;24(1):199-214. doi: 10.1016/j.soc.2014.09.006. Epub 2014 Oct 7.
7
Liver-directed therapies in metastatic colorectal cancer.转移性结直肠癌的肝脏导向治疗。
J Gastrointest Oncol. 2014 Oct;5(5):374-87. doi: 10.3978/j.issn.2078-6891.2014.064.
8
Metastasis-related processes show various degrees of activation in different stages of pancreatic cancer rat liver metastasis.转移相关过程在胰腺癌大鼠肝转移的不同阶段表现出不同程度的激活。
Oncol Res Treat. 2014;37(9):464-70. doi: 10.1159/000365496. Epub 2014 Jul 11.
9
Identification of prognostic inflammatory factors in colorectal liver metastases.结直肠癌肝转移中预后炎症因子的鉴定
BMC Cancer. 2014 Jul 28;14:542. doi: 10.1186/1471-2407-14-542.
10
Synergism from the combination of ulinastatin and curcumin offers greater inhibition against colorectal cancer liver metastases via modulating matrix metalloproteinase-9 and E-cadherin expression.乌司他丁和姜黄素联合使用通过调节基质金属蛋白酶-9 和 E-钙黏蛋白的表达对结直肠癌肝转移具有更强的抑制作用。
Onco Targets Ther. 2014 Feb 18;7:305-14. doi: 10.2147/OTT.S57126. eCollection 2014.